Home » Topics » Regulatory

Regulatory
RSS

Roche launches Fortovase in U.S.

Nov. 17, 1997

Anesta's Actiq denied FDA approval

Nov. 17, 1997

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

New formulation of amiodarone shows favorable hemodynamic effects

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

FDA approves Intron A for non-Hodgkin's lymphoma

Nov. 12, 1997

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears Fortovase

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...